1. CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration. Issue 2 (10th May 2011) Authors: McKibbin, Martin; Ali, Manir; Bansal, Shveta; Baxter, Paul D; West, Kumi; Williams, Grange; Cassidy, Frances; Inglehearn, Chris F Journal: British journal of ophthalmology Issue: Volume 96:Issue 2(2012) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗